Celcuity Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Celcuity Inc 's ROA in the second quarter of 2026?
Celcuity Inc recorded a cumulative net loss of $-226 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -41.41%.

However, within the Healthcare sector 500 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3928, from total ROA ranking in the first quarter of 2026 at 4617.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	355.24 %	88.19 %	85.38 %	74.3 %	-37.22 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-226	-193	-177	-163	-149
Return On Assets (TTM)	-41.41 %	-50.23 %	-52.7 %	-57.65 %	-64.23 %
CELC's Total Ranking	# 3928	# 4617	# 4110	# 4234	# 4145
Total Assets (TTM) in million	835	410	467	476	183
Seq. Total Assets Change	103.62 %	-12.09 %	-1.97 %	159.41 %	-15.83 %
Seq. Net Income Change	-	-	-	-	-

CELC's 5 Years Annual ROA >> Back to CELC Management Effectiveness >> Compare CELC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 31
Sector	# 501
Overall	# 3775

Return On Assets Statistics
High	Average	Low
-12.08 %	-42.64 %	-81.65 %
(Jun 30 2018)		(Jun 30 2021)

Financial Statements
Celcuity Inc 's Assets	$ 835 million	CELC's Balance sheet
Celcuity Inc 's Income	$ -79 million	Quarterly CELC's Income Statement
CELC's Income by Division		See CELC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	90.5 %	28.35 %	8.76 %	104.81 %	561.16 %
Total Assets in million	467	245	191	175	86
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-177	-112	-64	-40	-30
Annual Return On Assets	-37.95 %	-45.64 %	-33.42 %	-23.01 %	-34.56 %

CELC's 5 Years Annual ROA >> Back to CELC Management Effectiveness >> Compare CELC ROA to its Competitors

More Return On Assets Ratios
CELC's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CELC's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CELC's Competitors
Subscribers only: Roa for Celcuity Inc 's Suppliers
Subscribers only: Return On Assets for CELC's Customers

You may also want to know
CELC's Roi	CELC's Inventory Turnover Ratio	CELC's Growth Rates	CELC's Dividend Comparisons
	CELC's Profitability Ratios	CELC's Asset Turnover Ratio	CELC's Dividend Growth
CELC's Roe	CELC's Valuation Ratios	CELC's Financial Strength Ratios	CELC's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:32:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.